Hypertension Diagnostics, Inc.
HDII · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $1,630 | $2,611 | $2,152 | $178 |
| - Cash | $0 | $86 | $86 | $86 |
| + Debt | $0 | $651 | $775 | $4,685 |
| Enterprise Value | $1,630 | $3,176 | $2,841 | $4,777 |
| Revenue | $0 | $0 | $0 | $3,792 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $954 |
| % Margin | – | – | – | 25.2% |
| EBITDA | $135 | $226 | $3,500 | $72 |
| % Margin | – | – | – | 1.9% |
| Net Income | -$93 | -$11 | $3,294 | -$125 |
| % Margin | – | – | – | -3.3% |
| EPS Diluted | -0 | -0 | 0.024 | -0.001 |
| % Growth | -300% | -100.4% | 2,777.8% | – |
| Operating Cash Flow | -$892 | -$11 | $3,490 | -$389 |
| Capital Expenditures | -$0 | $0 | $0 | -$2 |
| Free Cash Flow | -$892 | -$11 | $3,490 | -$391 |